PGY2 Oncology Pharmacy Residency at Miami Cancer Institute Preceptors

Jessica Unzaga, Pharm.D., BCOP, is the Pharmacy Clinical Manager for Hematology and Stem Cell Transplant at the Miami Cancer Institute at Baptist Health South Florida (BHSF). She is a South Florida native and a graduate of the University of Florida College of Pharmacy. Dr. Unzaga completed her PGY1 pharmacy residency at the Veterans Affairs Tennessee Valley Healthcare System in Nashville and went on to complete a PGY2 residency in oncology at Methodist University Hospital affiliated with the University of Tennessee in Memphis. After residency she relocated back to South Florida to take on the role of Clinical Pharmacy Specialist at the Memorial Cancer Institute at the Memorial Healthcare System where she served many roles including infusion pharmacy operations and decentralized clinical services in Breast Cancer, Medical Oncology, Hematology, and Ambulatory Stem Cell Transplant clinics. Dr. Unzaga joined the BHSF family in 2018 as Pharmacy Clinical Coordinator and leads Clinical Pharmacy Services in Hematology, Stem Cell Transplant, and Cellular Therapy Programs at MCI and Baptist Hospital and collaborates with system leads to ensure the highest level of care and standardized practice for hematology patients throughout the health system. She has a special interest in teaching and education, she serves as a Courtesy Clinical Assistant Professor at the University of Florida and Nova Southeastern University Colleges of Pharmacy, and precepts pharmacy students in advanced pharmacy practice experiences in oncology. She has lectured at various colleges including Larkin University, Palm Beach Atlantic University, and the University of Tennessee colleges of pharmacy. She is an active member of ASH, ASTCT, FLASCO, FSHP, HOPA and NCODA. Dr. Unzaga had the honor of receiving the Preceptor of the Year Award for the PGY2 program in 2019 and she is thrilled to be serving as Director of the PGY2 Oncology Pharmacy Residency Program at MCI since 2022.

Lee Amaya, Pharm.D., BCIDP, AAHIVP is the Infectious Diseases (ID) Pharmacy Specialist in the oncology patient population with a focus in malignant hematology, blood & marrow transplantation (BMT), and cellular therapy at the Miami Cancer Institute (MCI) of Baptist Hospital of Miami (BHM). He grew up in Albuquerque, New Mexico and earned a Bachelor of Science in Biochemistry from the University of New Mexico. He then went on to obtain his Doctor of Pharmacy degree from the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences in 2018. After graduation, he completed his PGY1 pharmacy training at Nebraska Medicine in Omaha, Nebraska and then his PGY2 ID pharmacy residency training at Beaumont Hospital in Royal Oak, Michigan. His interests include viral infection reactivation, invasive fungal infections, febrile neutropenia, antibiotic allergies, HIV, healthcare informatics, medication safety, and personal development. He serves as the co-chair of the MCI Antimicrobial Stewardship (ASP) Collaborative where he works with the interdisciplinary team to develop and implement institutional antimicrobial use guidelines, protocols, and policies. He also serves as a preceptor for pharmacy interns and residents a rotation in Immunocompromised Infectious Diseases.

Audra Andersen, PharmD, BCOP practices as a clinical pharmacy specialist in the malignant hematology clinics at Miami Cancer Institute. She obtained her Doctor of Pharmacy degree from the University of Wisconsin-Madison and completed PGY1 residency training at Aurora Health Care in Milwaukee, WI. She practiced as an oncology pharmacist at University of Chicago Medicine and Northwestern Medicine, helping both programs establish their oncology specialty pharmacy services. She has an interest in precepting students and residents.

Michelle M. Bustamante., Pharm.D., BCPPS, is a Pharmacy Clinical Specialist at the Miami Cancer Institute at Baptist Health South Florida. She obtained her Doctor of Pharmacy degree in 2010 from the University of Florida, College of Pharmacy. After graduation, she completed a PGY1 with pediatric emphasis at Wolfson Children’s Hospital/Baptist Health, in Jacksonville, Florida, where she also obtained her teaching certificate from the University of Florida. Upon completion of residency, she began her pharmacy career as a Clinical Pharmacist at Joe DiMaggio Children’s Hospital. During her time at JDCH, Dr. Bustamante became a Clinical Specialist in Pediatric Hematology Oncology and also obtained her board certification in pediatric pharmacotherapy. Dr. Bustamante also serves as a mentor to pharmacy students in the mentorship program offered by her alma mater, precepts pharmacy students, as well as PGY1 and PGY2 pharmacy residents.

Eduardo A. Guizan Corrales, Pharm.D., BCOP is an Inpatient Oncology Clinical Pharmacy Specialist supporting the malignant hematology and hematopoietic stem cell transplant services at the Miami Cancer Institute, Baptist Health South Florida. Eduardo was born in Cuba, but later migrated to the United States and grew up in Miami, Florida. He received his Bachelor of Arts in Chemistry from The University of North Carolina and obtained his Doctor of Pharmacy degree from Nova Southeastern University in 2019. Dr. Guizan Corrales completed a PGY1 pharmacy practice residency with Baptist Hospital of Miami and a PGY2 oncology residency with Miami Cancer Institute. Dr. Guizan Corrales has an interest in teaching and precepts PGY1 and PGY2 pharmacy residents as well as students for the inpatient malignant hematology and bone marrow transplant learning experiences. He is currently an active member of the American Society of Health-System Pharmacists (ASHP), Hematology Oncology Pharmacy Association (HOPA), Florida Society of Clinical Oncology (FLASCO), and the American Society for Transplantation and Cellular Therapy (ASTCT).

Alyssa Donadio, Pharm.D., BCPS, BCOP, is an Inpatient Clinical Pharmacy Specialist specializing in Hematology and Stem Cell Transplant at Miami Cancer Institute, Baptist Health South Florida. She received her Bachelor’s degree in Biological Sciences from Cornell University and obtained her Doctor of Pharmacy degree from Albany College of Pharmacy and Health Sciences in 2017. She completed both her PGY1 Pharmacy Residency and PGY2 Oncology Residency at Baptist Hospital of Miami and Miami Cancer Institute. Dr. Donadio precepts PGY1 and PGY2 pharmacy residents and students for inpatient hematology/oncology and BMT/ stem cell transplant learning experiences. She is currently an active member of the Hematology Oncology Pharmacy Association (HOPA), American Society for Transplantation and Cellular Therapy (ASTCT), and the National Community Oncology Dispensing Association (NCODA).

Jorge J. Garcia, Pharm.D., MS, MHA, MBA, FACHE, obtained his Doctor of Pharmacy (Pharm.D.) and Master of Business Administration (MBA) from Nova Southeastern University (NSU) in 2010. He then transitioned to the University of Pittsburgh Medical Center (UPMC) to pursue an American Society of Health-System Pharmacy (ASHP)-accredited PGY1 and PGY2 Health-System Pharmacy Administration Residency and a Master of Science (MS) in Pharmacy Administration. He also completed a Master of Healthcare Administration (MHA) from Florida Atlantic University (FAU). Dr. García has previously served in the roles of inpatient pharmacy operations coordinator as well as director of pharmacy for system wide oncology pharmacy services.

Dr. García currently serves as an Assistant Vice President (AVP) at Baptist Health South Florida (BHSF) with responsibility for system-wide acute and ambulatory oncology pharmacy services as well as non-oncology infusion pharmacy services. Dr. García has pioneered pharmacy charge integrity and revenue management in the health-system setting and is a thought leader and national speaker in this area, as well as in the areas of alternative payment models, biosimilars, and value-based oncology care. Dr. García leads advocacy efforts at the national level to promote evaluation of safe and effective use of biosimilars, along with stakeholders’ engagement to support a more sustainable biosimilar pharmacoeconomic model. Dr. García has served as a board member at Florida Society of Clinical Oncology (FLASCO) since 2015 and is also a previous recipient of the FLASCO Above and Beyond Award, which honored his exceptional dedication and innovative contributions to the society. Dr. García also currently holds multiple committee appoints at the Association of Community Cancer Centers (ACCC), including the Oncology Pharmacy Education Network (OPEN) and the National Biosimilar Taskforce. In 2020, Dr. García was also appointed to the Board of Trustees at ACCC. In addition, Dr. García currently serves as faculty for the ASHP Foundation Pharmacy Leadership Academy (PLA). Dr. García is a fellow of the American College of Healthcare Executives (ACHE).

Lela Hall, Pharm.D., BCOP is an Oncology Clinical Specialist with experience in hematology, oncology and stem cell transplant. Lela received her BS in Biology from the University of Missouri-Columbia in 2000. Following undergraduate, Lela worked as a Cardiovascular-Neuroscience Research Specialist at the Dalton Cardiovascular Research Center. She later worked as an Education Coordinator and Branch Manager for Heartland Lions Eye Banks, working in tissue and solid organ transplant. Lela went on to receive her Pharm.D. from the University of Missouri-Kansas City in 2014, followed by a PGY1 Residency at the Southern Arizona Veterans Health Care System (SAVAHCS) in 2015, and a PGY2 Oncology Residency at Baptist Hospital of Miami in 2016. She has extensive experience in autologous and allogeneic stem cell transplant at another health-system for 3 years and returned to BHSF to help build the rapidly growing blood and marrow transplant and cellular therapy program. Lela has special interest in immunology and enjoys serving as a preceptor to both students and residents.

Elizabeth Jackson, Pharm.D., BCOP is currently a Clinical Pharmacy Specialist at Miami Cancer Institute (MCI), Baptist Health South Florida since April 2019. She completed her Doctor of Pharmacy degree at Temple University School of Pharmacy in 2010. Then, she pursued post-doctoral training which led to the completion of a PGY1 Pharmacy Practice residency at James J. Peters VA Medical Center (Bronx, NY) and PGY2 Oncology Pharmacy residency at Providence Alaska Medical Center (Anchorage, AK). Dr. Jackson became a board-certified oncology pharmacist in 2013. Prior to joining MCI, she was a Clinical Pharmacist at Providence Alaska Medical Center (Infusion Center Pharmacy) for 6.5 years. Upon joining MCI, Dr. Jackson served as one of the Clinical Pharmacy Specialists for Malignant Hematology/Oncology and Bone Marrow Transplant. In addition, she was the BMT ambulatory infusion unit pharmacist. In May 2021, she joined the Gynecology Oncology clinic as the clinical pharmacy specialist. She is a member of the Hematology Oncology Pharmacist Association (HOPA) and Florida Society of Clinical Oncology (FLASCO).

Leonette Kemp, Pharm.D., CPE, BCOP, is a Clinical Pharmacy Specialist II in Ambulatory Hematology/Oncology And Bone Marrow Transplant at the Miami Cancer Institute, Baptist Health South Florida. She obtained her Bachelor of Science in Biochemistry and Molecular Biology at the University of Georgia in Athens, GA. She then obtained her Doctor of Pharmacy degree from The University of Maryland, Baltimore (UMB) School of Pharmacy. Leonette completed a PGY1 Pharmacy Practice residency with emphasis in palliative care at UMB School of Pharmacy in 2007. She completed an American Society of Consultant Pharmacists (ASCP) traineeship in Parkinson’s disease at the Parkinson’s disease and movement disorders center during residency at the Northwestern University Feinberg School of Medicine in Chicago, Illinois. Leonette has been practicing in the areas of palliative care, pain management, and oncology for 15 years. She currently serves as one of the PGY2 oncology resident education co-coordinators for MCI/BHSF and is actively involved in several professional organizations including Hematology Oncology Pharmacists Association (HOPA), American Society of Health-System Pharmacists (ASHP), Florida Society of Clinical Oncology (FLASCO). Leonette enjoys mentoring and precepting pharmacy students and residents. She works closely with a dynamic team of providers and enjoys patient interaction and patient care.

Claudia Martin Diaz, Pharm.D., BCPS, BCOP, is an Inpatient Clinical Pharmacy Specialist specializing in Hematology and Stem Cell Transplant at Miami Cancer Institute, Baptist Health South Florida. She received her Bachelor’s degree in Chemistry from Saint Thomas University and obtained her Doctor of Pharmacy degree from University of Florida Collage of Pharmacy in 2019. She completed both her PGY1 Pharmacy Residency and PGY2 Oncology Residency at Baptist Hospital of Miami and Miami Cancer Institute. Dr. Martin Diaz has a strong interest in teaching and enjoys precepting PGY1 and PGY2 pharmacy residents and students for inpatient hematology/oncology and bone marrow transplant learning experiences. She appreciates working closely with the multidisciplinary team and patient interaction.

Dina Dumercy McHenry, Pharm.D., BCOP, MBA, CSSGB is the Director of Pharmacy at the Miami Cancer Institute. She received her Doctorate of Pharmacy from Florida A & M University and completed a Pharmacy Practice Residency with a focus in Oncology at Jackson Memorial Hospital/ FAMU. After her residency she completed an ASHP Oncology Patient Care Traineeship at the University of Texas MD Anderson Cancer Center. She has over 15 years of experience practicing in Oncology. In 2022 she obtained a Master's in Business Administration at the Louisiana State University. She currently serves as the co-chair of the MCI Oncology P&T Committee and is a former program director for a post graduate year 2(PGY2) residency who achieved ASHP accreditation within that programs first year. She is an active member of several professional and civic organizations including Hematology Oncology Pharmacist Association (HOPA), Florida Society of Clinical Oncology (FLASCO) Board of Directors, and American Society of Health-system Pharmacy (ASHP) at the local and national level. She has a passion for educating patients and caregivers about cancer treatment, patient safety and increasing cancer awareness.

Alga S. Ramos Morales, Pharm.D., MS, BCPS, BCOP, is currently the Solid Tumor Pharmacy Clinical Coordinator at the Miami Cancer Institute. She received her Doctor of Pharmacy degree from the University of Puerto Rico (UPR) in 2014. Dr. Ramos also completed a Master’s degree in Medicinal Chemistry at the UPR and her thesis was on warfarin pharmacogenomics. She completed her pharmacy practice residency training at Miami Veterans Administration Medical Center (VAMC) with a specialty in Health System Pharmacy Administration. Prior to joining Baptist Health South Florida, she worked as Enterprise Pharmacy Clinical Coordinator at Cancer Treatment Centers of America and as a Medical Science Liaison at Eli Lilly. From 2019 to 2021 she served as the Medication Safety and Quality Clinical Coordinator at the Miami Cancer Institute, where she monitored, evaluated and collaborated with multidisciplinary teams to prevent medication incidents in the Ambulatory, Inpatient, Research and Specialty Pharmacy Oncology settings. She obtained ASQ Lean Six Sigma Green Belt Certification in 2021. She precepts pharmacy residents and students for advanced pharmacy practice experiences in oncology, oncology informatics, and administration.

Vivian Nguyen, PharmD, BCPS practices as a Clinical Pharmacy Specialist specializing in Investigational Drug Services at the Miami Cancer Institute at Baptist Health South Florida. She earned her Bachelor of Science degrees in Biochemistry and Nutritional Science from the University of Florida, followed by her Doctor of Pharmacy degree from the University of Florida, College of Pharmacy, Jacksonville. After graduation, she completed both her PGY1 Pharmacy Practice and PGY2 Investigational Drugs and Research residency programs at The Johns Hopkins Hospital in Baltimore, Maryland. She also became board certified in Pharmacotherapy during that time. Dr. Nguyen possesses a strong interest in teaching and education, exemplified by her completion of a teaching certification through her residency program and her experience serving as a mentor and preceptor to students and residents.

Tiba Al Sagheer, Pharm.D. BCOP, BCACP, is a Clinical Pharmacy Specialist at the Miami Cancer Institute. She earned her Doctor of Pharmacy from Midwestern University. After graduation, Dr. Al Sagheer completed PGY1 pharmacy residency at the Mayo Clinic followed by PGY2 Oncology training at the University of Colorado Skaggs School of Pharmacy & Pharmaceutical Sciences. Dr. Al Sagheer currently practices in an ambulatory clinic as part of a multidisciplinary team where she is able to provide direct patient care, participate in clinical research, and education. She is passionate about education and has experience in both formal classroom teaching as well as students and resident precepting in the clinical setting. Dr. Al Sagheer is an active member of several professional organizations and currently serves on the American Society for Transplantation and Cellular Therapy (ASTCT) planning committee.

Moe Shwin, Pharm.D., BCOP, is the Clinical Manager of Oncology Pharmacy Services at Miami Cancer Institute at Baptist Health South Florida. He obtained his Doctor of Pharmacy degree from Nova Southeastern University, College of Pharmacy in 2012. Dr. Shwin completed both PGY1 Pharmacy residency and PGY2 Oncology specialty residency at Baptist Hospital of Miami. He currently serves as the co-chair of the Regimen Review Committee for Oncology, and and is involved with various committees and professional organizations. Dr. Shwin serves as an adjunct faculty member at Nova Southeastern University and a Courtesy Clinical Assistant Professor at the University of Florida.

Alyssa Strohbusch, Pharm.D., MS, CPh, BCOP practices as the clinical pharmacy specialist in neuro-oncology and sarcoma clinics at The Miami Cancer Institute. Equipped with a previous professional background in DNA analysis and human biometrics, she obtained her Doctor of Pharmacy degree from Pacific University and went on to complete her first-year residency training within the Intermountain Healthcare and specialty oncology training at Baptist MD Anderson Cancer Center. Alyssa is an active member of the Society of Neuro-oncology (SNO) and boasts multiple publications relating to the treatment of central nervous system malignancies. She also possesses a profound interest in personalized medicine and pharmacogenomics and holds Applied Pharmacogenomics Certification through the American College of Clinical Pharmacy (ACCP).

Monica Tadros, Pharm.D., BCPS, BCOP is an ambulatory Clinical Pharmacy Specialist at Miami Cancer institute, currently supporting the malignant hematology and hematopoietic stem cell transplant clinics. Dr. Tadros received her Doctor of Pharmacy degree in 2018 from Nova Southeastern University where she graduated with Highest Honors. She completed a PGY1 pharmacy practice residency with Baptist Hospital of Miami and a PGY2 oncology residency with Miami Cancer Institute. Dr. Tadros has a strong interest in teaching and precepting, having completed a teaching certificate through Nova Southeastern University’s ITALICSRx program, presented oncology lectures at Palm Beach Atlantic University School of Pharmacy as Adjunct Clinical Professor, and is a Courtesy Clinical Assistant Professor with the University of Florida. Dr. Tadros precepts students and residents on the ambulatory hematology rotation and is proud to have been awarded MCI‘s PGY2 Oncology Residency Preceptor of the Year award in 2021 and again in 2023. Dr. Tadros is an active member of several professional organizations including HOPA and FLASCO and is avidly involved in Kappa Psi Pharmaceutical Fraternity, Inc. where she has served as a past Satrap (President) of the Southeast Province and continues to serve on various regional and international committees.

Diana Van Ostran, PharmD, BCOP graduated from Nova Southeastern University in 2017 and continued on to complete a PGY1 residency program at Boca Raton Regional Hospital. In July of 2018, Dr. Van Ostran joined the Miami Cancer Institute pharmacy team and is currently working as a clinical specialist where she is an integral part of the medical oncology team. Although her priority is taking excellent care of patients, she also enjoys teaching residents and students as well as lecturing to educate others on the evolving world of oncology.

Kush Kumar, PharmD, BCOP practices as a clinical pharmacy specialist in medical oncology at Miami Cancer Institute – Plantation. Dr. Kumar work closely with Breast, Thoracic, GI, GU solid tumor clinics and also is an integral part of the pharmacy research team at MCI-Plantation. He received his Doctor of Pharmacy degree from Nova Southeastern University in 2018. Dr. Kumar completed a PGY1 pharmacy practice residency with Memorial Regional Hospital. He also earned his teaching certificate from the University of Connecticut. He worked for 2 years as oncology clinical pharmacist prior to completing his PGY2 Oncology Pharmacy residency with Miami Cancer Institute. He has an interest in precepting students and residents.

Frank Nyanin, Pharm.D., BCPS, BCOP graduated from Bernard J. Dunn School of Pharmacy – Shenandoah University in 2020. Dr. Nyanin completed his PGY1 residency program at Sentara RMH in Harrisonburg, VA followed by PGY2 residency training at Miami cancer institute, Baptist Health South Florida. After completing his residencies, Dr. Nyanin accepted a position as an in-patient clinical pharmacy specialist in medical oncology at Miami cancer institute, Baptist Health South Florida. Dr. Nyanin is very passionate about providing care for oncology patients and working with resident and students.

Ernesto Perez, Pharm.D. is the Operations Supervisor at Miami Cancer Institute. He obtained his undergraduate degree in Biology and Forensic Chemistry at Florida International University before completing his Doctor of Pharmacy degree from Nova Southeastern University in 2016. After completing a PGY1 Pharmacy Residency at Boca Raton Regional Hospital in, he joined the clinical pharmacist team at Baptist Hospital in 2017. Dr. Perez now helps oversee operations at Miami Cancer Institute and its satellite infusion sites and serves as preceptor for Oncology Pharmacy Operations.

Mayret Gonzalez, Pharm.D, BCPS, BCOP practices as the clinical pharmacy specialist in Cardio-Oncology and Genitourinary clinics at Miami Cancer Institute. Dr. Gonzalez received her Doctor of Pharmacy degree in 2018 from Nova Southeastern University. She completed a PGY1 pharmacy residency at Homestead Hospital, within Baptist Health South Florida. She is an adjunct professor at Larkin University where she teaches Arrhythmia Pathophysiology and Pharmacotherapy lectures. She is currently an active member of the American Society of Health-System Pharmacists (ASHP), the International Cardio-Oncology Society (ICOS), and the ICOS Pharmacy Working Group.

Khurrum Qureshi, Pharm.D, BCOP practices as the clinical pharmacy specialist in the head & neck, thoracic, skin and endocrine oncology at the Miami Cancer Institute. Dr. Qureshi received his Doctor of Pharmacy degree in 2019 from the University of Florida. He later returned to his hometown of Miami to complete a PGY1 pharmacy residency at Jackson Memorial Hospital and PGY2 oncology pharmacy residency at Baptist Hospital of Miami and Miami Cancer Institute. He enjoys teaching at all levels of pharmacy education including precepting students and residents as well as presenting to healthcare professionals at local and national conferences. He is currently an active member of American Society of Health-System Pharmacists (ASHP) and Hematology Oncology Pharmacy Association (HOPA).